HCN News & Notes

Anthony Belott Joins CleanSlate Centers as Chief Development Officer

NORTHAMPTON — CleanSlate Centers announced that Anthony Belott has joined the CleanSlate team as chief development officer. He will play a substantial role in establishing and fostering key external partnerships and alliances designed to aid CleanSlate’s strategic national expansion into new markets.

Belott brings extensive experience and expertise in healthcare and business development. Before joining CleanSlate, he served as senior vice president of Business Development at DSI Renal, then the fifth-largest for-profit operator of outpatient dialysis clinics in the U.S., until its merger with U.S. Renal Care. Prior to his leadership position at DSI, he served as vice president of U.S. HealthWorks, where he led the expansion of the second-largest operator of occupational medicine and urgent-care clinics in the country to more than 200 medical clinics and work sites in 19 states. He earned his bachelor’s degree in economics from the Wharton School of the University of Pennsylvania and his MBA in finance from the UCLA Anderson School of Management.

“I am delighted that Anthony has joined the CleanSlate team and look forward to working closely with him as a key member of our leadership team,” said Greg Marotta, president and CEO of CleanSlate Centers. “Having someone of Anthony’s caliber at the helm of our development group will accelerate CleanSlate’s ability to grow and provide addiction-treatment solutions for patients in more centers across the country. His addition to the CleanSlate team is part of a broader strategic effort to invest in our current clinics and staff while expanding access to our proven treatment approach.”

There are more than 2 million people in the U.S. suffering from substance-use disorders related to opioids. According to the American Society of Addiction Medicine — the nation’s leading addiction-medicine society, representing 3,700 physicians, clinicians, and other professionals — opioid addiction is defined as a primary, chronic, and relapsing brain disease. The award-winning CleanSlate program of care includes individualized treatment plans for each patient consisting of appropriate medication treatment prescribed by physicians, clear accountability, and supportive counseling.

CleanSlate currently provides care to patients in Massachusetts and Pennsylvania and will soon offer treatment services in Indiana. It continues to forge partnerships with healthcare providers and health insurers to meet the growing demand for evidence-based treatment options in communities across the country.

“I am very pleased to join CleanSlate and lead the development team,” Belott said. “I look forward to helping shape the organization’s strategy for expanding CleanSlate’s treatment footprint across the U.S. through current and new clinic locations and strategic partnerships so that more patients in need can receive the care they deserve.”